TERP API - Nanology Labs
Alternative Names: TERP-APILatest Information Update: 28 Sep 2025
At a glance
- Originator Nanology Labs
- Developer QurCan Therapeutics
- Class Antineoplastics; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Alzheimer's disease; Solid tumours
Most Recent Events
- 28 Sep 2025 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA (Parenteral)
- 28 Sep 2025 No recent reports of development identified for preclinical development in Solid-tumours in USA (Parenteral)
- 26 Aug 2021 TERP API - Nanology Labs is available for licensing as of 26 Aug 2021. https://www.nanologylabs.com/pipeline.html